Literature DB >> 9124583

Systemic and hepatic hemodynamic changes in acute liver injury.

A J Makin1, R D Hughes, R Williams.   

Abstract

Systemic and hepatic circulatory changes were studied in rats over the course of acute liver injury. Hepatic injury was induced by intraperitoneal injection of D-galactosamine (1.1 g/kg), and systemic and hepatic hemodynamics were measured over a 72-h period using a radioactive microsphere technique with direct measurement of arterial, portal venous, and hepatic venous blood oxygen content. Cardiac output increased to a maximum at 48 h, producing a marked increase (450%) in hepatic arterial blood flow so that it became the dominant supply of oxygen at the time of maximal hepatic injury. A subsequent increase in portal venous flow resulted in an overall increase in total hepatic blood flow of 500%. At this point the oxygen delivery by the hepatic arterial and portal venous systems was equal. These circulatory changes returned to control values by 72 h with recovery of liver function. These results demonstrate the development of a hyperdynamic circulation and a marked change in the normal relationship between portal venous and hepatic arterial blood flows that occur during hepatic injury.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9124583     DOI: 10.1152/ajpgi.1997.272.3.G617

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  10 in total

Review 1.  Animal models of acute hepatic failure.

Authors:  T M Rahman; H J Hodgson
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

2.  Hepato-cardiovascular response and its regulation.

Authors:  Xiang-Nong Li; Irving S Benjamin; Barry Alexander
Journal:  World J Gastroenterol       Date:  2005-02-07       Impact factor: 5.742

3.  Endothelin is an important determinant of renal function in a rat model of acute liver and renal failure.

Authors:  R Anand; D Harry; S Holt; P Milner; M Dashwood; D Goodier; M Jarmulowicz; K Moore
Journal:  Gut       Date:  2002-01       Impact factor: 23.059

4.  Hyperlactatemia in patients with non-acetaminophen-related acute liver failure.

Authors:  Pilar Taurá; Graciela Martinez-Palli; Julia Martinez-Ocon; Joan Beltran; Gerard Sanchez-Etayo; Jaume Balust; Teresa Anglada; Antoni Mas; Juan-Carlos Garcia-Valdecasas
Journal:  World J Gastroenterol       Date:  2006-03-28       Impact factor: 5.742

5.  Elevated resistive index in the hepatic artery as a predictor of fulminant hepatic failure in patients with acute viral hepatitis: a prospective study using Doppler ultrasound.

Authors:  Katsuaki Tanaka; Kazushi Numata; Manabu Morimoto; Kazuhito Shirato; Satoru Saito; Toshio Imada; Shinju Arata; Mitsugi Sugiyama
Journal:  Dig Dis Sci       Date:  2004-05       Impact factor: 3.199

6.  Protective effects of ellagic acid in D-galactosamine-induced kidney damage in rats.

Authors:  Adnan Ayhanci; Mustafa Cengiz; H Mehtap Kutlu; Djanan Vejselova
Journal:  Cytotechnology       Date:  2015-12-12       Impact factor: 2.058

7.  D-Galactosamine Intoxication in Experimental Animals: Is it Only an Experimental Model of Acute Liver Failure?

Authors:  Marek Saracyn; Robert Zdanowski; Marek Brytan; Grzegorz Kade; Zbigniew Nowak; Janusz Patera; Przemysław Dyrla; Jerzy Gil; Zofia Wańkowicz
Journal:  Med Sci Monit       Date:  2015-05-22

Review 8.  Ideal Experimental Rat Models for Liver Diseases.

Authors:  Sang Woo Lee; Sung Hoon Kim; Seon Ok Min; Kyung Sik Kim
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2011-05-31

9.  Porcine model characterizing various parameters assessing the outcome after acetaminophen intoxication induced acute liver failure.

Authors:  Karolin Thiel; Wilfried Klingert; Kathrin Klingert; Matthias H Morgalla; Martin U Schuhmann; Pamela Leckie; Yalda Sharifi; Nathan A Davies; Rajiv Jalan; Andreas Peter; Christian Grasshoff; Alfred Königsrainer; Martin Schenk; Christian Thiel
Journal:  World J Gastroenterol       Date:  2017-03-07       Impact factor: 5.742

10.  Amelioration of galactosamine-induced nephrotoxicity by a protein isolated from the leaves of the herb, Cajanus indicus L.

Authors:  Mahua Sinha; Prasenjit Manna; Parames C Sil
Journal:  BMC Complement Altern Med       Date:  2007-04-25       Impact factor: 3.659

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.